ICAM1 and neoplasm: In concordance with our previous results using ICAM-1 antibodies (Fig. 1), adhesion of tumor cells to ICAM-1 silenced LSECs was 2-fold lower than tumor adhesion to LSECs expressing ICAM-1 derived from mice injected with scramble siRNA (Fig. 6A).